Jan 6, 2026 08:12AM
Jan 6, 2026 08:00AM
Nov 10, 2025 04:05PM
Oct 13, 2025 04:07PM
Oct 13, 2025 04:05PM
Aug 6, 2025 04:05PM
May 14, 2025 04:05PM Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress
Apr 28, 2025 08:00AM
Mar 27, 2025 07:54AM
Mar 26, 2025 04:05PM
Mar 15, 2025 11:25AM
Jan 30, 2025 06:40AM
Jan 29, 2025 07:09AM
Jan 29, 2025 07:00AM Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Jan 9, 2025 07:00AM
Sep 16, 2024 12:18PM
Sep 16, 2024 11:55AM
Sep 16, 2024 07:01AM
Sep 16, 2024 07:00AM
Aug 9, 2024 07:00AM
Jun 20, 2024 06:10AM UBS Downgrades Zentalis Pharmaceuticals (ZNTL) to Neutral
Jun 18, 2024 02:19PM
Jun 18, 2024 01:32PM
Jun 18, 2024 12:13PM
Jun 18, 2024 11:58AM
Jun 18, 2024 07:32AM
Jun 18, 2024 07:00AM
Jun 18, 2024 07:00AM Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
Feb 27, 2024 07:00AM
Nov 6, 2023 07:18AM
Aug 9, 2023 07:00AM
Aug 1, 2023 07:00AM
Aug 1, 2023 07:00AM
Jun 6, 2023 06:03AM
Jun 6, 2023 06:00AM Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
May 25, 2023 05:39PM
May 25, 2023 05:38PM
May 10, 2023 07:00AM
Apr 26, 2023 10:00AM
Apr 17, 2023 09:03AM
Apr 17, 2023 09:00AM
Nov 9, 2022 07:00AM Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
Oct 24, 2022 07:02AM
Oct 24, 2022 07:00AM
Oct 3, 2022 05:32PM
May 16, 2022 07:02AM
May 16, 2022 07:00AM
Apr 8, 2022 01:22PM
Apr 8, 2022 01:00PM Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
Feb 24, 2022 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All